Mark A. Merchant
Revolution Medicines (United States) · 372 works · 10,443 citations · h-index 48
Top works
- A genetic map of the mouse with 4,006 simple sequence length polymorphisms
- A comprehensive genetic map of the mouse genome
- Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors
- Genome Maps IV 1993. Wall Chart
- Quantitative locus analysis of airway hyperresponsiveness in A/J and C57BL/6J mice
- Oncogenic ERBB3 Mutations in Human Cancers
- Intermittent Administration of MEK Inhibitor GDC-0973 plus PI3K Inhibitor GDC-0941 Triggers Robust Apoptosis and Tumor Growth Inhibition
- A Novel One-Armed Anti-c-Met Antibody Inhibits Glioblastoma Growth In vivo
- Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers
- MetMAb, the One-Armed 5D5 Anti-c-Met Antibody, Inhibits Orthotopic Pancreatic Tumor Growth and Improves Survival
- The Cancer Stem Cell Marker Aldehyde Dehydrogenase Is Required to Maintain a Drug-Tolerant Tumor Cell Subpopulation
- A Novel Tankyrase Small-Molecule Inhibitor Suppresses APC Mutation–Driven Colorectal Tumor Growth
- Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors
- Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent
- Bispecific antibodies with natural architecture produced by co-culture of bacteria expressing two distinct half-antibodies
- Suppressor of Fused Regulates Gli Activity through a Dual Binding Mechanism
- Noncovalent Wild-type–Sparing Inhibitors of EGFR T790M
- A transgene insertion creating a heritable chromosome deletion mouse model of Prader-Willi and Angelman syndromes
- Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation
- Loss of the Serine/Threonine Kinase Fused Results in Postnatal Growth Defects and Lethality Due to Progressive Hydrocephalus